Summary of the Chinese Society for Immunology (CSI) Symposium at AAI 2025
Source：CSI
2025-05-16
The 2025 Annual Meeting of the American Association of Immunologists (AAI 2025) was held in Honolulu, Hawaii from May 2 to May 7, 2025, with nearly 2,000 participants in attendance. In addition to classic fundamental immunology research, the conference focused on key topics such as neuroimmunology, computational immunology, systems immunology, tumor immunology, and novel immunotherapy technologies.
On the afternoon of May 5, under the organization of Prof. Yiwei Chu, Vice President of the Chinese Society for Immunology (CSI) and faculty at Fudan University Shanghai Medical College, CSI hosted its 14th symposium at the AAI annual meeting. The previous session was held in 2021, led by Prof. Bing Sun, then Vice President of CSI. This year's session, themed "Therapeutic Discovery and Development," was chaired by Prof. Yiwei Chu and Prof. Thirumala-Devi Kanneganti from St. Jude Children's Research Hospital (USA). More than 150 attendees participated in presentations and discussions.
Before the academic presentations began, Prof. Yiwei Chu provided an overview of the rapid growth of the CSI. CSI now has the largest membership in the world, with over 5,000 attendees at its annual meetings. The keynote speeches and breakout sessions consistently showcase top-tier talent and groundbreaking research. CSI’s flagship journal, Cellular & Molecular Immunology, boasts an impact factor of 21.8, ranking 5th among 181 immunology journals worldwide. Additionally, CSI actively organizes international conferences in collaboration with FIMSA, China-Japan-Korea, China-UK, and China-Germany partnerships, while maintaining ongoing cooperation with AAI to host sessions at its annual meetings. These initiatives highlight CSI's global presence and commitment to high-quality academic exchange.
The session featured 5 distinguished immunologists from China, presenting cutting-edge research aligned with the conference theme:
• Prof. Di Wang (Zhejiang University School of Medicine): Another Face of the Pyroptotic Executor in Regulating Physiological and Cellular Homeostasis
• Prof. Yiwei Chu (Fudan University Shanghai Medical College): Foxp3 Confers Long-Term Efficacy of CAR-T Cells via Metabolic Reprogramming
• Prof. Hanjie Li (Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences): Peripheral Microglia: Discovery and Beyond
• Prof. Yangxin Fu (Tsinghua University School of Medicine): Orchestrating Intratumoral DC-T Cell Immunity for Local and Distal Tumor Control
• Prof. Yi Zhang (Biotherapy Center, First Affiliated Hospital of Zhengzhou University): Clinical Practice of Cellular Immunotherapy for Cancer
These five compelling presentations sparked enthusiastic discussions and insightful questions from immunology researchers, who praised China's advanced immunology research and exceptional talent. As a special segment of the event, Prof. Yiwei Chu, representing CSI, presented honorary certificates to the session chairs and invited speakers, expressing gratitude for their support of CSI’s international academic collaborations.
On the afternoon of May 5, under the organization of Prof. Yiwei Chu, Vice President of the Chinese Society for Immunology (CSI) and faculty at Fudan University Shanghai Medical College, CSI hosted its 14th symposium at the AAI annual meeting. The previous session was held in 2021, led by Prof. Bing Sun, then Vice President of CSI. This year's session, themed "Therapeutic Discovery and Development," was chaired by Prof. Yiwei Chu and Prof. Thirumala-Devi Kanneganti from St. Jude Children's Research Hospital (USA). More than 150 attendees participated in presentations and discussions.
Before the academic presentations began, Prof. Yiwei Chu provided an overview of the rapid growth of the CSI. CSI now has the largest membership in the world, with over 5,000 attendees at its annual meetings. The keynote speeches and breakout sessions consistently showcase top-tier talent and groundbreaking research. CSI’s flagship journal, Cellular & Molecular Immunology, boasts an impact factor of 21.8, ranking 5th among 181 immunology journals worldwide. Additionally, CSI actively organizes international conferences in collaboration with FIMSA, China-Japan-Korea, China-UK, and China-Germany partnerships, while maintaining ongoing cooperation with AAI to host sessions at its annual meetings. These initiatives highlight CSI's global presence and commitment to high-quality academic exchange.
The session featured 5 distinguished immunologists from China, presenting cutting-edge research aligned with the conference theme:
• Prof. Di Wang (Zhejiang University School of Medicine): Another Face of the Pyroptotic Executor in Regulating Physiological and Cellular Homeostasis
• Prof. Yiwei Chu (Fudan University Shanghai Medical College): Foxp3 Confers Long-Term Efficacy of CAR-T Cells via Metabolic Reprogramming
• Prof. Hanjie Li (Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences): Peripheral Microglia: Discovery and Beyond
• Prof. Yangxin Fu (Tsinghua University School of Medicine): Orchestrating Intratumoral DC-T Cell Immunity for Local and Distal Tumor Control
• Prof. Yi Zhang (Biotherapy Center, First Affiliated Hospital of Zhengzhou University): Clinical Practice of Cellular Immunotherapy for Cancer
These five compelling presentations sparked enthusiastic discussions and insightful questions from immunology researchers, who praised China's advanced immunology research and exceptional talent. As a special segment of the event, Prof. Yiwei Chu, representing CSI, presented honorary certificates to the session chairs and invited speakers, expressing gratitude for their support of CSI’s international academic collaborations.
